These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 11884042)

  • 21. Surgical management of the axilla: do intramammary nodes matter?
    Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
    Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low axillary sampling in clinically node-negative operable breast cancer.
    Parmar V; Hawaldar R; Nadkarni MS; Badwe RA
    Natl Med J India; 2009; 22(5):234-6. PubMed ID: 20334043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower nodal counts in axillary dissection following neoadjuvant chemotherapy: are there implications?
    Callcut RA; Breslin TM
    Am J Surg; 2006 Jun; 191(6):830-1. PubMed ID: 16720160
    [No Abstract]   [Full Text] [Related]  

  • 25. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.
    Ponzone R; Cont NT; Maggiorotto F; Cassina E; Mininanni P; Biglia N; Sismondi P
    J Clin Oncol; 2009 Nov; 27(33):5547-51. PubMed ID: 19826123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of level III clearance in patients with axillary and sentinel node positive breast cancer.
    Dillon MF; Advani V; Masterson C; O'Loughlin C; Quinn CM; O'Higgins N; Evoy D; McDermott EW
    Ann Surg; 2009 May; 249(5):834-9. PubMed ID: 19387317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy, axillary dissection and breast cancer: radiation oncologist's viewpoint.
    Bansal M; Mohanti BK
    Natl Med J India; 2002; 15(3):154-7. PubMed ID: 12186329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing accuracy of axillary sentinel lymph node frozen section for breast cancer.
    Jensen AJ; Naik AM; Pommier RF; Vetto JT; Troxell ML
    Am J Surg; 2010 May; 199(5):629-35. PubMed ID: 20466107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
    Samphao S; Eremin JM; El-Sheemy M; Eremin O
    Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore.
    Tan LG; Tan YY; Heng D; Chan MY
    Singapore Med J; 2005 Dec; 46(12):693-7. PubMed ID: 16308642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan.
    Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S
    Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A four node axillary sampling trial on breast cancer patients.
    Tanaka K; Yamamoto D; Kanematsu S; Okugawa H; Kamiyama Y
    Breast; 2006 Apr; 15(2):203-9. PubMed ID: 16061382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of two sentinel nodes accurately stages the axilla in breast cancer.
    Kennedy RJ; Kollias J; Gill PG; Bochner M; Coventry BJ; Farshid G
    Br J Surg; 2003 Nov; 90(11):1349-53. PubMed ID: 14598413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
    Dabbs DJ; Fung M; Johnson R
    Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.
    Motomura K; Egawa C; Komoike Y; Nagumo S; Koyama H; Inaji H
    Ann Surg Oncol; 2006 Jul; 13(7):985-9. PubMed ID: 16788761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reliability and accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer.
    Pogacnik A; Klopcic U; Grazio-Frković S; Zgajnar J; Hocevar M; Vidergar-Kralj B
    Cytopathology; 2005 Apr; 16(2):71-6. PubMed ID: 15787648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
    Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A
    Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.